T315I MUTATION TREATMENT

Welcome to the Brand page for “T315I MUTATION TREATMENT”, which is offered here for The mark consists of grey letters and numbers for t315i with the 3 being a swirl design where the outside is purple and the inside is orange and the words mutation treatment are in purple title case letter with a purple plus sign in front of these words.;t three one five one; t three one fifty one;the color(s) grey, purple and orange is/are claimed as a feature of the mark.;medical testing for diagnostic and prognostic purposes in the field of cancer, kinase inhibitor treatment failure, and genetics; medical testing for diagnostic and treatment purposes in the field of cancer research, kinase inhibitor treatment failure research, and genetics research; providing medical information to medical professionals, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; medical testing services, kinase inhibitor treatment failure and genetic testing for diagnosis and treatment of cancer; genetic testing for medical purposes;t315i mutation treatment;providing scientific analysis and informational reports based upon results of laboratory testing in the field of kinase inhibitor treatment failure, genetics, epigenetics and cancer; scientific research in the fields of kinase inhibitor treatment failure, genetics, epigenetics and cancer; laboratory research in the field of the field of cancer research, kinase inhibitor treatment failure, and genetics; providing laboratory research services in the field of kinase inhibitor treatment failure and genetic testing;.

Its status is currently believed to be active. Its class is unavailable. “T315I MUTATION TREATMENT” is believed to be currently owned by “PALADIN LABS INC.”